Publications by authors named "Leah Burn"
Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005-2020).
Vector Borne Zoonotic Dis
April 2023
Article Synopsis
- Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe, but accurate data on its incidence is lacking, motivating a systematic review of studies from multiple databases covering 2005 to 2020.
- The review identified 61 unique studies across 25 European countries, revealing significant differences in study design and case definitions, with only 21% adhering to the standardized definitions established by the EUCALB.
- Findings showed the highest LB incidences in Belgium, Finland, the Netherlands, and Switzerland (over 100 cases per 100,000 population per year), while some areas displayed much higher localized rates, indicating substantial variability in disease burden across the continent.
Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005-2020).
Vector Borne Zoonotic Dis
April 2023
Article Synopsis
- Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe, with a systematic review showing significant variation in incidence reporting across 25 countries from 2005 to 2020.
- Most countries (84%) employed passive surveillance methods, while only a few (Bulgaria, France, Poland, Romania) used standardized case definitions as recommended by public health authorities, which hampered cross-country comparisons.
- The highest LB incidences were recorded in Estonia, Lithuania, Slovenia, and Switzerland (over 100 cases/100,000 PPY), with an estimated 128,888 cases reported annually and 24% of Europeans living in high-incidence areas.
Lyme borreliosis (LB), a tick bite-transmitted infection caused by () complex spirochetes, is the most common tickborne disease in Europe. Studies in European countries have reported LB seroprevalence (prevalence of antibodies to infection) and diagnostic strategies used for testing. We conducted a systematic literature review to summarize contemporary LB seroprevalence in Europe.
View Article and Find Full Text PDFSince its initial identification in 1986, Lyme disease has been clinically diagnosed in 29 provinces in China; however, national incidence data are lacking. To summarize Lyme disease seropositivity data among persons across China, we conducted a systematic literature review of Chinese- and English-language journal articles published during 2005‒2020. According to 72 estimates that measured IgG by using a diagnostic enzyme-linked assay (EIA) alone, the seropositivity point prevalence with a fixed-effects model was 9.
View Article and Find Full Text PDF